Impact ledger
Dentsply Sirona Inc. (XRAY): the developments shaping its investment case
Follow the evidence affecting Dentsply Sirona Inc.. Review the key developments below. Continue in Market Ontology to test your assumptions, examine related opportunities, and save the investment case you want to track.
Research Dentsply Sirona Inc. · $399/mo
Test assumptions, examine opportunities, and save your research.
Material developments
2026-09-09 · 4 reports
Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms Full-Year 2026 Guidance
Channel: Direct earnings report, beating EPS expectations but with revenue decline and maintained guidance.
mixed· 1-3m
2026-09-09
Dentsply Sirona reports Q2 adjusted EPS of $0.52 and maintains $3.5B-$3.6B sales outlook
Channel: Direct earnings report impact, exceeding EPS expectations and maintaining full-year revenue guidance, which may alleviate some investor concerns about future performance.
Bullish· 1-3m
2026-09-17
Envista Holdings Corporation Hosts 2026 Investor Day
Channel: As a major competitor in the dental equipment and consumables market, Envista's strategic updates, particularly regarding new product launches, market share ambitions, or technological advancements, could signal competitive pressures or opportunities for Dentsply Sirona.
watch· 1-3m
Event impact log
6 events mapped to XRAY since 2026-09-09. Evidence through 2026-09-17.
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-09-17 | Envista Holdings Corporation Hosts 2026 Investor Day | As a major competitor in the dental equipment and consumables market, Envista's strategic updates, particularly regarding new product launches, market share ambitions, or technological advancements, could signal competitive pressures or opportunities for Dentsply Sirona. | watch | 1-3m | 0.40 |
| 2026-09-09 | Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms Full-Year 2026 Guidance | Direct earnings report, beating EPS expectations but with revenue decline and maintained guidance. | mixed | 1-3m | 0.70 |
| 2026-09-09 | Dentsply Sirona Beats Q2 Adjusted EPS Consensus at $0.52 and Reaffirms FY26 Outlook | Direct financial performance and management guidance. | mixed | 1-3m | 0.70 |
| 2026-09-09 | Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 Guidance | Direct earnings report, better-than-expected EPS driven by cost management or favorable product mix despite revenue contraction. Reaffirmed guidance provides near-term stability. | mixed | 1-3m | 0.70 |
| 2026-09-09 | Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 Outlook | Direct financial performance exceeding expectations and reaffirmed guidance signaling stability. | Bullish | 1-3m | 0.80 |
| 2026-09-09 | Dentsply Sirona reports Q2 adjusted EPS of $0.52 and maintains $3.5B-$3.6B sales outlook | Direct earnings report impact, exceeding EPS expectations and maintaining full-year revenue guidance, which may alleviate some investor concerns about future performance. | Bullish | 1-3m | 0.70 |
Continue this research
Build your Dentsply Sirona Inc. investment case. Continue from the evidence above, change the assumptions the developments move, and save the work to revisit as the case develops.
This ledger is regenerated from Market Ontology's public event pipeline. View the XRAY entity page →